Boston Scientific Corporation (BSX)
Boston Scientific (BSX) Surpasses Q3 Earnings and Revenue Estimates
Boston Scientific (BSX) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.50 per share a year ago.
Boston Scientific's stock climbs on Q3 sales and earnings beat
Medical-products company Boston Scientific reported third-quarter results before market open.
Boston Scientific lifts annual profit forecast on strong demand for heart devices
Boston Scientific raised its annual profit forecast and exceeded Wall Street's estimates for third-quarter profit on Wednesday, driven by robust demand for its heart devices, sending its shares higher 1.1% to $88.94 in premarket trading.
Boston Scientific Earnings, Sales Top Q3 Views; Stock Eyes High
Boston Scientific earnings and sales beat Q3 views early Wednesday. The medtech giant's shares, right at record highs, rose before the open,
Boston Scientific Q3 Earnings Preview
Boston Scientific (NYSE: BSX) is scheduled to report its Q3 2024 results on Wednesday, October 23. We expect the company to report revenues and earnings slightly below the consensus estimates.
Boston Scientific (BSX) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
Get a deeper insight into the potential performance of Boston Scientific (BSX) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
This Boston Scientific Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Boston Scientific (BSX) Increases Yet Falls Behind Market: What Investors Need to Know
Boston Scientific (BSX) concluded the recent trading session at $87, signifying a +0.27% move from its prior day's close.
Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth
Boston Scientific (BSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Reasons Why Growth Investors Shouldn't Overlook Boston Scientific (BSX)
Boston Scientific (BSX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Will FARAPULSE Line Aid Boston Scientific's Q3 Earnings?
BSX is expected to have registered strong growth in the Asia Pacific, which is led by strength in China and Japan.
Boston Scientific Corporation (BSX) Hit a 52 Week High, Can the Run Continue?
Boston Scientific (BSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
